Skip to main content

Peer Review reports

From: c-MET/VEGFR-2 co-localisation impacts on survival following bevacizumab therapy in epithelial ovarian cancer: an exploratory biomarker study of the phase 3 ICON7 trial

Original Submission
7 Oct 2021 Submitted Original manuscript
24 Oct 2021 Reviewed Reviewer Report
27 Oct 2021 Reviewed Reviewer Report
18 Nov 2021 Reviewed Reviewer Report
16 Dec 2021 Author responded Author comments - Robert D Morgan
Resubmission - Version 2
16 Dec 2021 Submitted Manuscript version 2
19 Jan 2022 Reviewed Reviewer Report
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
20 Jan 2022 Editorially accepted
11 Feb 2022 Article published 10.1186/s12916-022-02270-y

You can find further information about peer review here.

Back to article page